Author(s): Murugan S, Chandra Sekhar R

Email(s): msm_apcp07@yahoo.com

DOI: 10.5958/0974-360X.2017.00456.5   

Address: Murugan S1*, Chandra Sekhar R2
1Department of Pharmaceutical Analysis, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamilnadu, India.
2Seven Hills College of Pharmacy, Tirupathi, Andhra Pradesh, India.
*Corresponding Author

Published In:   Volume - 10,      Issue - 8,     Year - 2017


ABSTRACT:
A facile and rapid isocratic reverse phase high performance liquid chromatography assay method has been developed and validated for the determination of fingolimod in bulk and tablet dosage form. The column was equilibrated for at least 30 min and separation was achieved by using kromofil-ODS C18 (150 x 4.6 mm, particle size 5 µm). The column was maintained at ambient temperature (25°C). The mobile phase employed was methanol: water (60:40 v/v). The eluent was monitored using UV detector at 220 nm. A volume of 10µL of standard and sample solutions was injected in to the HPLC. The flow rate was 1.0 mL /min. The retention times were 4.525 min for fingolimod. The method was found to be linear in the range of 25 - 150 µg/mL. The developed method was validated as per ICH guidelines. The developed method was found to be simple, precise, accurate, selective and sensitive.


Cite this article:
Murugan S, Chandra Sekhar R. Method Development and Validation of Fingolimod in Bulk and Tablet Dosage Form by RP-HPLC. Research J. Pharm. and Tech. 2017; 10(8): 2573-2576. doi: 10.5958/0974-360X.2017.00456.5

Cite(Electronic):
Murugan S, Chandra Sekhar R. Method Development and Validation of Fingolimod in Bulk and Tablet Dosage Form by RP-HPLC. Research J. Pharm. and Tech. 2017; 10(8): 2573-2576. doi: 10.5958/0974-360X.2017.00456.5   Available on: https://rjptonline.org/AbstractView.aspx?PID=2017-10-8-26


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available